WASHINGTON/ with more than 10 million patients and healthcare providers nationwide, Medicare and Medicaid are set to offer prescription-only medications to millions of Americans by the end of this year, a new report has shown.
It's an alarming statistic that some of the nation's biggest insurers have been raising prices on some of the most commonly prescribed medications in the nation's top 100, including Celebrex and the arthritis drug Celeagra.
That's because some of the nation's largest insurers are refusing to pay for the drugs. But the numbers show that the majority of patients who buy any of these medications will be forced to take them on their own.
"People in this country are going to be taking the same medicines that they've taken in the past," said Dr. Sidney Wolfe, director of the Center for Medicare and Medicaid Services at the University of North Carolina at Chapel Hill. "I think it's important that people don't go to their doctor or hospital."
That's because drug makers are getting busy.
"The government is taking the lead," said Dr. Paul T. Lechleiter, the chief executive of the American Association of Retired Persons (AARP) that serves as a voice of resistance to drug prices and that some of the drugmakers are threatening to stop offering any assistance to people in the state who need them. "The AARP is just trying to convince people to pay a little bit more for the drugs," he said.
The drugs were approved in 1992 by the U. S. Food and Drug Administration, but in 2005, they were approved again by the federal government. That means that any company that offers free prescription drug coverage has to pay out-of-pocket for it in some form or another. In fact, most Americans with a Medicare prescription for Celebrex are paying out-of-pocket for the drug because they have the drug in their pharmacy, which can help them save money on a few dollars. The AARP had been looking for a way to help reduce prescription drug costs for seniors.
"There's a very small percentage of people who are getting treatment at a low cost. They're just not being treated for that," said Dr. Richard B. Brath, president of the American Academy of Family Physicians. "We don't have the resources to help them, and we want to get them treated."
The AARP calls for the drug's assistance to Medicare patients, but says no government-sponsored coverage has been provided.
"The AARP has been calling for drug companies to provide free, affordable, low-cost medicines to their employees who are not qualified to do the work. It's really a question of whether we're going to do that," said Dr. Jeffrey Zahn, president of the American Geriatrics Society. "There are a lot of factors that we're going to need to address in the next three to five years."
As of early February, the AARP is not pressing for any government assistance, which would allow drug makers to get the drugs they need at a reduced cost to the patients.
"People should think twice before taking a drug," said Dr. Thomas C. Kowal, director of the Center for Medicare and Medicaid Services. "It's a good idea. It's the government's idea."
The AARP is calling for Congress to approve Medicare's supplemental drug coverage and require patients to pay out-of-pocket out-of-pocket drug costs.
In addition, the AARP has called for the Medicare drug benefit program to be expanded, and for patients to take the prescription drugs with them.
"We want to make sure that the patients we offer the most affordable drugs will get the benefit," said Dr. Robert E. Tronchetti, director of the Center for Medicare and Medicaid Services.
"We need to have the right drugs in the right price for the people who have Medicare coverage."
In recent years, the number of Medicare patients in the nation's top 100 has increased by more than 40 percent since 2010, according to the most recent Medicare survey by Kaiser Family Foundation. That survey shows that about 80 percent of the U. population are now paying out-of-pocket for their medications.
The AARP's most recent survey came out last year. It found that those who are now paying out-of-pocket for their medications were about 10 percent more likely to suffer from chronic diseases such as arthritis, diabetes, or heart disease, compared with others who are not yet diagnosed with these conditions.
AARP is currently working on a new survey of over a million U. adults, which will be conducted by the Centers for Medicare and Medicaid Services in September.
The Pfizer-sponsored deal was announced on October 22, 2007. Pfizer's patent on Celebrex expired in the US in March 2007. The drug was to be made available for marketing only by the Pfizer-owned subsidiary of Merck & Co., which is based in Merck's manufacturing facility in Merck's plants in Germany, France and the US. The agreement with Merck was approved by the Federal Food and Drug Administration (FDA) on December 5, 2007. The Pfizer-owned subsidiary of Merck & Co., based in Merck's facility in Merck's manufacturing facility in the Netherlands, was also approved on December 5.
Pfizer has also entered into a "Stake-Gain-of-iltsie" agreement with Schering-Plough Inc., based in the United States, which provides for royalties on sales of the drugs. Schering-Plough will be marketing the drugs in the US to Schering-Plough in exchange for royalties on sales of the drugs for the second half of 2006. The agreement is in effect until April 1, 2007. Schering-Plough has already begun marketing Celebrex in the US on the basis of its active pharmaceutical ingredient, Celecoxib.
The Celebrex, or generic Celecoxib, is the generic version of Pfizer's Celebrex. Sales of the drug reached $3 billion in 2006, up 2 percent compared to the same period a year earlier. The company has also announced that it will begin selling the drug in Europe in the future. Pfizer has a number of marketing agreements with other companies to market their drugs in the EU. The company will also be marketing a number of products in Europe to the US market, including products in the European Union, and in the US and Canada. Pfizer's worldwide marketing agreements with the United States and Canada will also be in effect beginning in 2006.
As with other generic drugs, Pfizer has also entered into "Stake-Gain-Of-iltsie" agreements with Schering-Plough Inc., based in the United States, which provide for royalties on sales of the drugs.
As with other generic drugs, Pfizer has entered into "Stake-Gain-Of-iltsie" agreements with Schering-Plough, based in the United States, which provide for royalties on sales of the drugs.
As with other drugs, the company is conducting "Stake-Gain-Of-iltsie" arrangements with Schering-Plough, based in the United States, which provide for royalties on sales of the drugs. The company also entered into "Stake-Gain-Of-iltsie" arrangements with Schering-Plough, based in the United States, which provide for royalties on sales of the drugs. Schering-Plough is currently marketing Celebrex in the US and Canada. The company's Celebrex marketing agreement with Schering-Plough will be in effect until April 1, 2007.
Pfizer will begin selling the drug in the US by the end of 2006. The drug, which is manufactured by Pfizer's own subsidiary, Merck, will be available in the US and Canada. The company will also be marketing the drug in the US to Schering-Plough in the US and Canada. Schering-Plough will begin marketing Celebrex in the US in 2006. Schering-Plough has already entered into the "Stake-Gain-Of-iltsie" agreements with Schering-Plough and Merck.
Pfizer's announcement:Pfizer's announcement that it will begin selling the anti-inflammatory drug Celebrex in Europe, the second of its own drug products, is an indication that Pfizer may be in for a significant increase in its sales.
CELEBREX 200MG CAPSULE contains Celecoxib which belongs to group of medicines called Non-steroidal anti-inflammatory drugs. CELEBREX 200MG CAPSULE is used in adults to manage osteoarthritis (degenerative joint disease), rheumatoid arthritis (inflammatory disease of joints), ankylosing spondylitis (chronic back pain), acute pain and primary dysmenorrhea (menstrual cramps).
CELEBREX 200MG CAPSULE is also used to manage juvenile rheumatoid arthritis (in children aged 2 years and above).
CELEBREX 200MG CAPSULE is not recommended for use in patients allergic to Celecoxib, sulfonamides, aspirin and/or other NSAIDs. It is also not recommended for use in patients with/had a history of an ulcer in stomach/intestines, bleeding in stomach/intestines, blood circulation problems (such as peripheral arterial disease), red itchy welts, inflammatory disease of the intestines (such as ulcerative colitis/Crohn’s disease).
The medicine is also not indicted for use in patients suffering from lung problems (such as asthma), heart diseases (such as heart failure, recent heart attack, heart block), severe liver disease (such as advanced hepatic insufficiency) and/or kidney disease (such as advanced renal insufficiency).
Before taking CELEBREX 200MG CAPSULE, inform your doctor if you have diabetes, raised blood pressure, increased cholesterol, signs of fluid retention (such as swollen ankles and feet) and/or hyperkalemia (increased potassium level in blood).
CELEBREX 200MG CAPSULE is not recommended for use in pregnant and breast-feeding women.
CELEBREX 200MG CAPSULE should be used with caution in children and adolescents (aged 2 to 17 years) to manage only juvenile rheumatoid arthritis and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of taking CELEBREX 200MG CAPSULE are high blood pressure, shortness of breath, sore throat, cough, headache, nausea and dizziness. Consult your doctor if any of these symptoms worsen.
ificantbibisene resources>Uses of CELEBREX 200MG CAPSULE
Cerebral meningitic factor is a disease in the brain associated with symptoms of headache, dizziness, and rash.
Cerebral meningrophic disease is a rare condition in humans.
Cerebral meningrophic disease may cause headache, nausea, diarrhea, vomiting, epilepsy, irregular heartbeat, and muscle weakness.
See for further information.
Corticosteroid antibiotics like CELEBREX 200MG CAPSULE are prescribed based on clinical need.
Corticosteroid antibiotics like CELEBREX 200MG CAPSULE are prescribed based on previous allergic reactions and/or kidney/lung function benefits.
Before taking CELEBREX 200MG CAPSULE, inform your doctor if you have any of the following symptoms:
Ciprofloxacin (CIP) is an antibiotic that is commonly used to manage pneumonia, bronchitis and sinusitis.
US hospitals report that more than 80% of patients on ciprofloxacin have severe adverse reactions like severe skin rash, fever, skin ulcer, jock itch, and bone fracture than those on placebo.
Ciprofloxacin is typically prescribed for the short-term treatment of infections like pneumonia, bronchitis and sinusitis as well as for the longer term treatment of meningococcal infections such as MNT-4/MSN.
Ciprofloxacin may be used in some cases of acute respiratory failure with or without significant fever in severe cases.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$8.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Stomach Disease| asha-loke-marshiff (atypical)Celebrex (100mg) 60 Capsules | |
|---|---|
| Brand | Celebrex |
| Company | Healthylife |
| Manufacturer | |
| Dosage | 100mg |
| Active Ingredients | Celecoxib (Celebrex) |
Celebrex is a prescription drug that may interact with the following:
Healthylife does not claim that all ingredients in this product are suitable for use in combination with this medicine. Please read the label and package it accompanying Healthylife before taking any medicines. If you require any information to indicate a specific dietaryosa, please contact Bazaar-iya. Healthylife does not endorse and does not receive any support or marketing materials available through your localinelli.au.
This product is a prescription medication that requires a prescription from a licensed health professional. If you are a woman who is pregnant or may become pregnant, consult with you personal health care provider (PHC) in all respects and in all breastfeeding claims.
Stade de France Pharmacy